15 Downloads (Pure)

Abstract

The great challenge for oncologists treating patients who are developing or progressing with metastatic disease is to be able to offer a truly personalized and targeted therapy that can have an early and meaningful effect on the course of the disease. At present the known molecular markers are limited in their frequency and reliability in determining the use of newer chemotherapies. Professor Eng discusses the challenges faced in ensuring timely and effective treatments based on the molecular profile of the tumour and the potential role of real-time analysis of mutational changes in the tumour when progression occurs.

Original languageEnglish
JournalColorectal Disease
Volume20
Issue numberS4
Pages (from-to)49-51
Number of pages3
ISSN1463-1318
DOIs
Publication statusPublished - 1 May 2018
Event13th Scientific and Annual Meeting of the European Society of Coloproctology - Acropolis Palais des Congrès, Nice, France
Duration: 26 Sep 201828 Sep 2018
Conference number: 13
https://www.escp.eu.com/conference-and-events/escp-nice-2018/registration-and-fees

Conference

Conference13th Scientific and Annual Meeting of the European Society of Coloproctology
Number13
LocationAcropolis Palais des Congrès
CountryFrance
CityNice
Period26/09/201828/09/2018
Internet address

Bibliographical note

Abstract no. P090

Fingerprint Dive into the research topics of 'Session 2: Mutational discordance: the big challenge in personalized treatments – any solutions?'. Together they form a unique fingerprint.

  • Cite this